Skip to main content
Sarah Holstein, MD, Oncology, Omaha, NE

SarahA.HolsteinMDPhD, FACP

Oncology • Omaha, NE

Hematologic Oncology

Professor

Join to view full profile

Dr. Holstein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Holstein's full profile

Already have an account?

  • Office

    986840 Nebraska Medical Ctr
    Omaha, NE 68198
    Phone+1 402-559-8500
    Fax+1 402-559-6520

Education & Training

  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 2006 - 2010
  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 2004 - 2006
  • University of Iowa Roy J. and Lucille A. Carver College of Medicine
    University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2004

Certifications & Licensure

  • NE State Medical License
    NE State Medical License 2016 - 2026
  • IA State Medical License
    IA State Medical License 2021 - 2025
  • NY State Medical License
    NY State Medical License 2013 - 2017
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology
  • National Board of Physicians and Surgeons Hematology
  • National Board of Physicians and Surgeons Internal Medicine
  • National Board of Physicians and Surgeons Medical Oncology

Awards, Honors, & Recognition

  • Fellowship American College of Physicians, 2018
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Geranylgeranyl Diphosphate Synthase Inhibitor and Proteasome Inhibitor Combination Therapy in Multiple Myeloma
    Sarah A. Holstein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • In Vitro and in Vivo Activity of Melflufen in Amyloidosis
    Sarah A. Holstein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • The Effect of Age and CD34+ Stem Cell Dose on Autologous Hematopoietic Stem Cell Transplantation Outcomes in Multiple Myeloma _ Single Institution Experience
    Sarah A. Holstein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Results of a Phase I Study of Pnk-007, Allogeneic, Off the Shelf NK Cell, Post Autologous Transplant in Multiple Myeloma (NCT02955550) 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Friday Scientific Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • In Vivo Evaluation of Novel Geranylgeranyl Diphosphate Synthase InhibitorsClinically Relevant Abstract 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Pulled Myeloma Drug Improves Survival in Trial
    Pulled Myeloma Drug Improves Survival in TrialDecember 12th, 2024
  • Distinguished Scientist: Sarah Holstein, MD, PhD
    Distinguished Scientist: Sarah Holstein, MD, PhDFebruary 11th, 2021
  • Finding a Needle in a Haystack of Mutations: Using Whole Genome Sequencing to Identify Patients with Low-Risk Myeloma
    Finding a Needle in a Haystack of Mutations: Using Whole Genome Sequencing to Identify Patients with Low-Risk MyelomaJuly 20th, 2020
  • Join now to see all

Committees

  • Member, Alliance Multiple Myeloma Committee 2014 - Present
  • Member, NCCN Multiple Myeloma Panel 2015 - 2019

Professional Memberships

Dr. Sarah Holstein, Dr. Sarah Holstein, MD, Dr. S Holstein, Dr. Sarah A. Holstein